Paperpal Prime Logo

Prostate : Impact Factor & More

eISSN: 1097-0045pISSN: 0270-4137

Key Metrics

CiteScore
6.8
Impact Factor
< 5
SNIP
0.9
Recommended pre-submission checks
Powered by Paperpal by Editage

Prostate Journal Specifications

Overview
Publisher WILEY
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1980
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Prostate ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Prostate

Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI-RADS 3 Lesions: A Two-Center Retrospective Study.
  • 1 Sep 2026
  • The Prostate
Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity.
  • 1 Sep 2026
  • The Prostate
Predictive Value of [-2]proPSA-Related Indices for Prostate Cancer Detection Years Before Prostate-Specific Antigen Elevation: Insights From a Five-Year Longitudinal Screening Cohort.
  • 2 Aug 2026
  • The Prostate
Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era.
  • 2 Aug 2026
  • The Prostate
Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer.
  • 2 Aug 2026
  • The Prostate
Treatment of Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy.
  • 2 Aug 2026
  • The Prostate
Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI-RADS 3 Lesions: A Two-Center Retrospective Study.
  • 1 Sep 2026
  • The Prostate
Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity.
  • 1 Sep 2026
  • The Prostate
Predictive Value of [-2]proPSA-Related Indices for Prostate Cancer Detection Years Before Prostate-Specific Antigen Elevation: Insights From a Five-Year Longitudinal Screening Cohort.
  • 2 Aug 2026
  • The Prostate
Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era.
  • 2 Aug 2026
  • The Prostate
Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer.
  • 2 Aug 2026
  • The Prostate
Treatment of Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy.
  • 2 Aug 2026
  • The Prostate

FAQs on Prostate